One River Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-801
Closed -$52.7K 306
2024
Q3
$52.7K Buy
+801
New +$73.5K 0.01% 276
2024
Q1
Sell
-247
Closed -$24.6K 299
2023
Q4
$24.6K Sell
247
-4,761
-95% -$400K ﹤0.01% 291
2023
Q3
$502K Buy
5,008
+243
+5% +$27.1K 0.02% 245
2023
Q2
$582K Buy
4,765
+3,367
+241% +$449K 0.07% 149
2023
Q1
$208K Buy
1,398
+1,142
+446% +$188K 0.01% 277
2022
Q4
$45.8K Buy
+256
New +$41.9K ﹤0.01% 350

Other funds holding MRNA

One River Asset Management's MRNA Position: Q4 2024 in Review

One River Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 801 shares — an estimated $52.7K sold.

One River Asset Management first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $582K in Q2 2023. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • One River Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • One River Asset Management sold 801 Moderna shares in Q4 2024, an estimated $52.7K.
  • One River Asset Management first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
  • One River Asset Management's Moderna position peaked at $582K in Q2 2023.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on One River Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.